MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

01 Aug 2026 Evaluate
The revenue for the June 2026 quarter is pegged at Rs. 2069.65 millions, about 5.57% up against Rs. 1960.47 millions recorded during the year-ago period.A slim rise of 16.05% was recorded in the Net profit for the quarter ended June 2026 to Rs. 211.31  millions  From Rs. 182.08 millions.OP of the company witnessed a marginal growth to 436.34 millions from 394.54 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 2069.65 1960.47 5.57 2069.65 1960.47 5.57 8868.71 7827.48 13.30
Other Income 17.44 5.93 194.10 17.44 5.93 194.10 83.54 62.24 34.22
PBIDT 436.34 394.54 10.59 436.34 394.54 10.59 1792.67 1461.98 22.62
Interest 55.00 58.40 -5.82 55.00 58.40 -5.82 230.76 185.41 24.46
PBDT 381.34 336.14 13.45 381.34 336.14 13.45 1561.91 1276.57 22.35
Depreciation 99.91 97.52 2.45 99.91 97.52 2.45 399.19 343.37 16.26
PBT 281.43 238.62 17.94 281.43 238.62 17.94 1162.72 933.20 24.59
TAX 70.12 56.54 24.02 70.12 56.54 24.02 286.62 249.39 14.93
Deferred Tax 9.12 6.54 39.45 9.12 6.54 39.45 27.29 52.99 -48.50
PAT 211.31 182.08 16.05 211.31 182.08 16.05 876.10 683.81 28.12
Equity 93.65 88.65 5.64 93.65 88.65 5.64 93.65 88.65 5.64
PBIDTM(%) 21.08 20.12 4.76 21.08 20.12 4.76 20.21 18.68 8.22
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..